Clinical Trial

Bepirovirsen Liver Biopsy Study

Name: Bepirovirsen Liver Biopsy Study — clinical trial record (NCT07696520)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GSK Biopsy

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Bepirovirsen Liver Biopsy study is a single centre open label phase II study to examine the antiviral and immunological effects of bepirovirsen in CHB patients both treated and untreated with HBsAg\<1000 IU/ml

Trial Details

NCT Number	NCT07696520
Lead Sponsor	National University Health System, Singapore Collaborators: A*Star, National University of Singapore
Conditions	HEPATITIS B CHRONIC, Hepatitis B Chronic Infection
Enrollment	30 participants
Start Date	2026-07-01
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-10